Trial intelligence / Profile preview

Stress Index (SSI) during sevoflurane–alfentanil anesthesia

2006-003765-14Phase 3Completed

Sponsor
GE HealthCare
Start
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of sevoflurane, alfentanil and propofol, sponsored by GE HealthCare. Primary endpoint: Change in stress index value. Started Jul 2006; status: completed.

02

Drugs

sevofluranealfentanilpropofol

Beyond the preview

Go deeper on 2006-003765-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003765-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call